Multimodal Quantified Analysis of Facial Movements: Comparison Between Pathological and Control Subjects
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Oct 13, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying facial palsy, a condition that affects a person's ability to move their facial muscles. The researchers want to understand how facial movements differ between people with facial palsy and healthy individuals. They will use advanced technology, such as motion capture and devices that measure muscle activity, to get precise information about these movements. By comparing the results from patients with facial palsy to those without, the trial aims to improve our understanding of this condition and how patients perceive their own movement and treatment outcomes.
To participate in this trial, individuals must be over 18 years old and can either be healthy volunteers or patients with facial palsy, regardless of how severe their condition is. Participants will undergo various tests to measure their facial movements and eye tracking, which helps researchers see how they focus on their condition. This study is currently recruiting participants, and anyone interested should ensure they can provide informed consent and are not facing any severe skin or speech disorders that would prevent them from participating.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects with no known facial pathology (healthy volunteers) OR
- • Patients with peripheral facial palsy, irrespective of grade, whether or not previously treated
- • Subject with written informed consent
- • Subject over 18 years of age
- • Subject affiliated to a social security scheme
- Exclusion Criteria:
- • Subjects with severe skin disorders that do not allow the application of electrodes or photo reflective markers
- • Subjects with speech disorders making it impossible to pronounce the sounds \[o\] and \[pu\]
- • Subject unable to provide written informed consent
- • Subjects under guardianship, curators or safeguard of justice
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, Picardie, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials